EasyNat TB-CPA Diagnostic Kit

Ustar Biotechnologies (Hangzhou) Ltd

  • The EasyNat TB-CPA Diagnostic Kit is designed as a screening tool for active pulmonary tuberculosis (TB) to improve the detection rate in people with suspected TB infection. The kit allows for rapid diagnostics that can be conducted without highly specific and expensive equipment as well as highly skilled staff. It is useful in many low-income settings where tuberculosis control is lacking.
Product description
  • The EasyNat TB-CPA Diagnostic Kit is designed as a screening tool for active pulmonary tuberculosis (TB) to improve the detection rate in people with suspected TB infection. The kit allows for rapid diagnostics that can be conducted without highly specific and expensive equipment as well as highly skilled staff. It is useful in many low-income settings where tuberculosis control is lacking.
Target region(s)

Currently sold in China, Singapore, Philippines, Indonesia, India, South Africa, Canada and USA. Interview with representative

However, there are 22 countries in which Ustar Biotechnologies identifies as “high TB burden” including Afghanistan, Bangladesh, Brazil, Cambodia, China, Democratic Republic of Congo, Ethiopia, India, Indonesia, Kenya, Mozambique, Myanmar, Nigeria, Pakistan, Philippines, Russian Federation, South Africa, United Republic of Tanzania, Thailand, Uganda, Viet Nam, Zimbabwe. Source: Ustar Biotechnologies

Distributors/implementing organizations

Ustar Biotechnologies (Hangzhou) Ltd.

Market suggested retail price

$6-$8 (including sample preparation, amplification and detection)

Competitive landscape

Laboratory based TB Diagnostic methods such as: Acid Fast Bacilli (AFB) Smear, Culture, Immunological Testing, PCR-based Testing. Nucleic Acid based testing for Mycobacterium tuberculosis are also produced by these companies: Gen-Probe, Inc., Syngene, Inc., Roche Molecular Systems, Inc., Becton, Dickinson, & Co., Cepheid. Acid Fast Bacilli (AFB) Smear, Culture, Immunological Testing, and PCR-based Testing. More information on all of these methods, and contrasts between them and the EasyNAT are available on the Ustar website.

SDG targeted
  • Goal 3: to improve and promote good health.

    Increase access to tuberculosis diagnostics for patients living in areas without advanced healthcare facilities. More than 2 billion people are infected with TB bacilli and one in every 10 of those people will become sick with active TB in his or her lifetime. TB inflicts people in developing countries with higher rates of incidence, drug-resistance, and mortality.

The @AutodeskFdn blogged about our how-to guide for communities writing proposals for development projects https://t.co/MlRH1H0x2F